<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02095730</url>
  </required_header>
  <id_info>
    <org_study_id>CXL-CHR 1</org_study_id>
    <nct_id>NCT02095730</nct_id>
  </id_info>
  <brief_title>Corneal Cross-Linking Comparing Variables</brief_title>
  <official_title>Study of Safety and Efficacy of Photochemically Induced Collagen Cross-Linking at an Irradiance of 18 mW/cm2 as Constant or Pulsed Treatment in Eyes With Unstable Corneas Due to Keratoconus, Ectasia, or Post-Incisional Refractive Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Crowd Health Research, LTD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Crowd Health Research, LTD</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the Safety and Efficacy of Corneal Cross Linking in&#xD;
      a Continuous Beam versus Pulsed Treatments across epithelium on and epithelium off surfaces.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>2 years</time_frame>
    <description>Uncorrected visual acuity</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Unstable Corneas</condition>
  <arm_group>
    <arm_group_label>Epi-On Continuous</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous beam of UV light treating cornea with surface epithelium present</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epi-Off Continuous</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous beam of UV light treating cornea without surface epithelium present</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epi-On Pulsed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pulsed beam of UV light treating cornea with surface epithelium present</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Epi-Off Pulsed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pulsed beam of UV light treating cornea without surface epithelium present</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epithelium-On Riboflavin</intervention_name>
    <description>Riboflavin 0.1% Phosphate Sodium solution with Benzalkonium Chloride Preservative</description>
    <arm_group_label>Epi-On Continuous</arm_group_label>
    <arm_group_label>Epi-On Pulsed</arm_group_label>
    <other_name>Vitamin B2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epithelium-Off Riboflavin</intervention_name>
    <description>Riboflavin 0.1% Phosphate Sodium solution</description>
    <arm_group_label>Epi-Off Continuous</arm_group_label>
    <arm_group_label>Epi-Off Pulsed</arm_group_label>
    <other_name>Vitamin B2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>UV Light - Continuous Beam</intervention_name>
    <description>5 minutes of constant UV exposure to saturated cornea</description>
    <arm_group_label>Epi-Off Continuous</arm_group_label>
    <arm_group_label>Epi-On Continuous</arm_group_label>
    <other_name>Peschke Vario CCL-365 UV system</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>UV Pulsed Beam</intervention_name>
    <description>5 minutes of UV exposure to saturated cornea, alternating 1 minute of treatment with 1 minute rest for a total time of 10 minutes</description>
    <arm_group_label>Epi-Off Pulsed</arm_group_label>
    <arm_group_label>Epi-On Pulsed</arm_group_label>
    <other_name>Peschke Vario CCL-365 UV system</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria Keratoconus:&#xD;
&#xD;
          -  12 years of age or older&#xD;
&#xD;
          -  Having a clinical diagnosis of progressive keratoconus consistent with:&#xD;
&#xD;
               1. An increase of ≥ 1.00 D in the steepest keratometry value&#xD;
&#xD;
               2. An increase of ≥ 1.00 D in astigmatism manifest refraction&#xD;
&#xD;
               3. A myopic shift (decrease in the spherical equivalent) of ≥ 0.50 D on subjective&#xD;
                  manifest refraction&#xD;
&#xD;
          -  Presence of central or inferior steepening on the topography map.&#xD;
&#xD;
          -  Axial topography consistent with keratoconus&#xD;
&#xD;
          -  Steepest keratometry (Kmax) value ≥ 47.00 D&#xD;
&#xD;
          -  Signed written informed consent&#xD;
&#xD;
          -  Willingness and ability to comply with schedule for follow-up visits&#xD;
&#xD;
          -  Contact lens removal prior to evaluation and treatment&#xD;
&#xD;
        Inclusion Criteria Post-Surgical Ectasia:&#xD;
&#xD;
          -  History of having undergone a keratorefractive procedure and:&#xD;
&#xD;
               1. Steepening by topography&#xD;
&#xD;
               2. Thinning of cornea&#xD;
&#xD;
               3. Shift in the position of thinnest portion of cornea&#xD;
&#xD;
               4. Change in refraction with increasing myopia&#xD;
&#xD;
               5. Development of myopic astigmatism&#xD;
&#xD;
               6. Development of irregular astigmatism&#xD;
&#xD;
               7. Loss of Best Spectacle Corrected Visual Acuity&#xD;
&#xD;
          -  At least two of the above criteria must be present.&#xD;
&#xD;
        Inclusion Criteria Intacts:&#xD;
&#xD;
          -  Should the patient have undergone prior Intacs or other intra-corneal ring segment&#xD;
             surgery for keratoconus or post-surgical ectasia at least 6 months prior, and is also&#xD;
             experiencing at least two of the above ectasia symptoms, they can be included in the&#xD;
             study.&#xD;
&#xD;
               1. These patients would have the choice of ring explant before Cross-Linking.&#xD;
&#xD;
               2. Cross-Linking may still be performed if the patient wishes to retain the rings.&#xD;
&#xD;
          -  Should a patient's situation due to factors such as significantly high myopia or&#xD;
             astigmatism should warrant simultaneous placement of Intacs and cross-linking in the&#xD;
             investigators opinion, then this option can be offered to the patient. Such&#xD;
             interventions would be tracked as a different arm of the study.&#xD;
&#xD;
        Inclusion Criteria RK/AK Fluctuation:&#xD;
&#xD;
          -  History of having undergone radial keratotomy (RK) and or astigmatic keratotomy (AK)&#xD;
             surgery.&#xD;
&#xD;
          -  Expressing complaints about difficulties due to vision changing during the same day.&#xD;
&#xD;
          -  A difference in their Manifest Refraction (MRx) of greater than 0.75 D measured on the&#xD;
             same day, at least 6 hours apart.&#xD;
&#xD;
          -  Intacs surgery will not be considered in patients with RK/AK.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Eyes classified as either normal, atypical normal,&#xD;
&#xD;
          -  Corneal pachymetry ≤ 350 microns at the thinnest point measured by Orbscan, Pentacam,&#xD;
             or ultrasound in the eye to be treated&#xD;
&#xD;
          -  A history of chemical injury or delayed epithelial healing in the eye to be treated.&#xD;
&#xD;
          -  A known sensitivity to study medications&#xD;
&#xD;
          -  Patients with significant nystagmus or any other condition that would prevent a steady&#xD;
             gaze during the treatment&#xD;
&#xD;
          -  Inability to cooperate with diagnostic tests.&#xD;
&#xD;
          -  Patients with a current condition that, in the investigator's opinion, would interfere&#xD;
             with or prolong epithelial healing.&#xD;
&#xD;
          -  Taking Vitamin C (ascorbic acid) supplements within 1 week of the cross-linking&#xD;
             treatment.&#xD;
&#xD;
          -  Patients who are unable to remain comfortable and stable, and tolerate a lid speculum&#xD;
             for the appointed period of time for the procedure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy A Tanchel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Liberty Laser Eye Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Travis A Johnson, Bachelor's</last_name>
    <phone>571-234-5678</phone>
    <phone_ext>104</phone_ext>
    <email>tjohnson@libertylasereye.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nancy A Tanchel, MD</last_name>
    <phone>571-234-5678</phone>
    <phone_ext>103</phone_ext>
    <email>ntanchel@libertylasereye.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>LaserVue Eye</name>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <zip>95403</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Jay Bansal, MD</last_name>
      <phone>707-522-6200</phone>
      <email>bansal@laservue.com</email>
    </contact>
    <investigator>
      <last_name>Jay Bansal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icon Lasik</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80210</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Richard Anderson, OD</last_name>
      <phone>720-524-1001</phone>
      <email>ra@icondenver.com</email>
    </contact>
    <investigator>
      <last_name>Douglas Campbell, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gulani Vision Institute</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Arun Gulani, MD</last_name>
      <phone>904-296-7393</phone>
      <email>gulanivision@gulani.com</email>
    </contact>
    <investigator>
      <last_name>Arun Gulani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eye Consultants of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30339</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Teresa Long</last_name>
      <phone>404-351-2220</phone>
      <email>teresa_long@eyeconsultants.net</email>
    </contact>
    <investigator>
      <last_name>W. Barry Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwest Center for Sight</name>
      <address>
        <city>Des Plaines</city>
        <state>Illinois</state>
        <zip>60016</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>James Katz, MD</last_name>
      <phone>847-824-3127</phone>
      <email>jamesakatz@aol.com</email>
    </contact>
    <investigator>
      <last_name>James Katz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bond Eye Associates</name>
      <address>
        <city>Pekin</city>
        <state>Illinois</state>
        <zip>61554</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>William Bond, MD</last_name>
      <phone>309-353-6660</phone>
      <email>pekineye@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>William Bond, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Discover Vision Center</name>
      <address>
        <city>Leawood</city>
        <state>Kansas</state>
        <zip>66211</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Misty Robe, Associate's</last_name>
      <phone>816-478-1230</phone>
      <email>mrobe@discovervision.com</email>
    </contact>
    <investigator>
      <last_name>John Doane, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Eye Center</name>
      <address>
        <city>Hattiesburg</city>
        <state>Mississippi</state>
        <zip>39402</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Cameron Griffith, MD</last_name>
      <phone>318-464-0306</phone>
      <email>csgriff1@earthlink.net</email>
    </contact>
    <investigator>
      <last_name>Cameron Griffith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Clinic Eye Specialists</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Stephanie Sekscinski</last_name>
      <phone>417-820-9393</phone>
      <email>stephanie.sekscinski@mercy.net</email>
    </contact>
    <investigator>
      <last_name>Shachar Tauber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LASIK of Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89123</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Valerie Serett</last_name>
      <phone>702-636-2010</phone>
      <email>vserette@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Richard Rothman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rajy Rouweyha, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>James Lewis MD PC</name>
      <address>
        <city>Elkins Park</city>
        <state>Pennsylvania</state>
        <zip>19027</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>James Lewis, MD</last_name>
      <phone>215-886-9090</phone>
      <email>jslewis@jameslewis.com</email>
    </contact>
    <investigator>
      <last_name>James Lewis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Eye Institute</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17112</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Sherrie Reed</last_name>
      <phone>717-657-2020</phone>
      <email>crosslinkstudy@memorialeye.com</email>
    </contact>
    <investigator>
      <last_name>Bennett Chotiner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erik Chotiner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolina Eye Care</name>
      <address>
        <city>Mt. Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Helga Sandoval, MD</last_name>
      <phone>843-881-3937</phone>
      <email>helga.sandoval@carolinaeyecare.com</email>
    </contact>
    <investigator>
      <last_name>Kerry Solomon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charlene Grice, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loden Vision Centers</name>
      <address>
        <city>Goodlettsville</city>
        <state>Tennessee</state>
        <zip>37072</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Katie Lambeth</last_name>
      <phone>615-859-3937</phone>
      <email>klamberth@lodenvision.com</email>
    </contact>
    <investigator>
      <last_name>James Loden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Parkhurst NuVision</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Amy Ford</last_name>
      <phone>210-428-6788</phone>
      <email>nuvision.amy@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Gregory D Parkhurst, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Liberty Laser Eye Center</name>
      <address>
        <city>Vienna</city>
        <state>Virginia</state>
        <zip>22182</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Travis A Johnson, Bachelor's</last_name>
      <phone>571-234-5678</phone>
      <phone_ext>104</phone_ext>
      <email>tjohnson@libertylasereye.com</email>
    </contact>
    <investigator>
      <last_name>Nancy A Tanchel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <study_first_submitted>March 20, 2014</study_first_submitted>
  <study_first_submitted_qc>March 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2014</study_first_posted>
  <last_update_submitted>March 21, 2014</last_update_submitted>
  <last_update_submitted_qc>March 21, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>crosslinking</keyword>
  <keyword>cornea</keyword>
  <keyword>keratoconus</keyword>
  <keyword>ectasia</keyword>
  <keyword>irradiance</keyword>
  <keyword>riboflavin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Riboflavin</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

